Shungu, Dikoma C.

Amino Acid Neurotransmitters Assessed by Proton Magnetic Resonance Spectroscopy: Relationship to Treatment Resistance in Major Depressive Disorder

Price, R. B., Shungu, D. C., Mao, X., Nestadt, P., Kelly, C., Collins, K. A., Murrough, J. W., Charney, D. S., & Mathew, S. J. (2009) · Biological Psychiatry

Treatment of Major DepressionAdvanced MRI Techniques and Applications

Cited by 270

A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder

Milak, M. S., Proper, C. J., Mulhern, S. T., Parter, A. L., Kegeles, L. S., Ogden, R. T., Mao, X., Rodriguez, C. I., Oquendo, M. A., Suckow, R. F., et al. (2016) · Molecular Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 144

Investigation of Cortical Glutamate–Glutamine and γ-Aminobutyric Acid in Obsessive–Compulsive Disorder by Proton Magnetic Resonance Spectroscopy

Simpson, H. B., Shungu, D. C., Bender, J., Mao, X., Xu, X., Slifstein, M., & Kegeles, L. S. (2012) · Neuropsychopharmacology

Obsessive-Compulsive Spectrum DisordersAdvanced MRI Techniques and Applications

Cited by 138

The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder

Abdallah, C. G., Jackowski, A., Salas, R., Gupta, S., Sato, J. R., Mao, X., Coplan, J. D., Shungu, D. C., & Mathew, S. J. (2017) · Neuropsychopharmacology

Treatment of Major DepressionTryptophan and brain disorders

Cited by 123

Prefrontal cortical GABA abnormalities are associated with reduced hippocampal volume in major depressive disorder

Abdallah, C. G., Jackowski, A., Sato, J. R., Mao, X., Kang, G., Cheema, R., Coplan, J. D., Mathew, S. J., & Shungu, D. C. (2015) · European Neuropsychopharmacology

Treatment of Major DepressionStress Responses and Cortisol

Cited by 67

Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial

Milak, M. S., Rashid, R., Dong, Z., Kegeles, L. S., Grunebaum, M. F., Ogden, R. T., Lin, X., Mulhern, S. T., Suckow, R. F., Cooper, T. B., et al. (2020) · JAMA Network Open

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 63

Decreased choline and creatine concentrations in centrum semiovale in patients with generalized anxiety disorder: Relationship to IQ and early trauma

Coplan, J. D., Mathew, S. J., Mao, X., Smith, E. L. P., Hof, P. R., Coplan, P. M., Rosenblum, L. A., Gorman, J. M., & Shungu, D. C. (2006) · Psychiatry Research: Neuroimaging

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesAdvanced MRI Techniques and Applications

Cited by 45

Reduced hippocampal N-acetyl-aspartate (NAA) as a biomarker for overweight

Coplan, J. D., Fathy, H. M., Abdallah, C. G., Ragab, S. A., Kral, J. G., Mao, X., Shungu, D. C., & Mathew, S. J. (2014) · NeuroImage: Clinical

Advanced MRI Techniques and ApplicationsNeurogenesis and neuroplasticity mechanisms

Cited by 28

Multimodal and simultaneous assessments of brain and spinal fluid abnormalities in chronic fatigue syndrome and the effects of psychiatric comorbidity

Natelson, B. H., Mao, X., Stegner, A. J., Lange, G., Vu, D., Blate, M., Kang, G., Soto, E., Kapusuz, T., & Shungu, D. C. (2017) · Journal of the Neurological Sciences

Fibromyalgia and Chronic Fatigue Syndrome ResearchLong-Term Effects of COVID-19

Cited by 17